LVW Advisors LLC trimmed its position in shares of Chemed Co. (NYSE:CHE – Free Report) by 2.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 861 shares of the company’s stock after selling 25 shares during the quarter. LVW Advisors LLC’s holdings in Chemed were worth $553,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Rise Advisors LLC acquired a new position in shares of Chemed during the first quarter worth about $26,000. GAMMA Investing LLC acquired a new position in shares of Chemed during the fourth quarter worth about $37,000. Principal Securities Inc. acquired a new position in shares of Chemed during the fourth quarter worth about $51,000. SRS Capital Advisors Inc. increased its stake in shares of Chemed by 110.6% during the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock worth $58,000 after acquiring an additional 52 shares during the period. Finally, Mather Group LLC. acquired a new position in Chemed during the first quarter worth about $67,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, Director Patrick P. Grace sold 284 shares of the stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total value of $153,638.32. Following the sale, the director now directly owns 3,270 shares in the company, valued at $1,769,004.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Kevin J. Mcnamara sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the sale, the chief executive officer now owns 108,549 shares in the company, valued at $61,605,899.46. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 284 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $540.98, for a total transaction of $153,638.32. Following the sale, the director now owns 3,270 shares in the company, valued at approximately $1,769,004.60. The disclosure for this sale can be found here. Insiders have sold 5,784 shares of company stock worth $3,240,053 over the last ninety days. 3.32% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Get Our Latest Report on Chemed
Chemed Trading Down 0.6 %
Shares of CHE opened at $539.54 on Tuesday. The firm’s 50-day moving average is $556.04 and its two-hundred day moving average is $588.78. Chemed Co. has a twelve month low of $492.84 and a twelve month high of $654.62. The firm has a market capitalization of $8.17 billion, a P/E ratio of 29.04, a PEG ratio of 2.23 and a beta of 0.43.
Chemed (NYSE:CHE – Get Free Report) last released its quarterly earnings results on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing the consensus estimate of $5.09 by ($0.41). The business had revenue of $589.23 million during the quarter, compared to analyst estimates of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. Analysts predict that Chemed Co. will post 21.54 EPS for the current year.
Chemed Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Stockholders of record on Thursday, May 30th were given a $0.40 dividend. The ex-dividend date was Thursday, May 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.30%. Chemed’s dividend payout ratio is presently 8.61%.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles
- Five stocks we like better than Chemed
- Business Services Stocks Investing
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.